| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/21/2023 | -9.76% | B of A Securities | $10 → $8 | Maintains | Underperform |
| 06/08/2023 | 46.64% | SVB Securities | → $13 | Initiates Coverage On | → Outperform |
| 04/26/2023 | 170.73% | JMP Securities | $34 → $24 | Maintains | Outperform |
| 01/19/2023 | 103.05% | UBS | → $18 | Upgrades | Neutral → Buy |
| 01/09/2023 | — | Jefferies | Upgrades | Hold → Buy | |
| 11/17/2022 | 283.53% | JMP Securities | $37 → $34 | Maintains | Market Outperform |
| 04/22/2022 | 317.37% | JMP Securities | $52 → $37 | Maintains | Market Outperform |
| 01/21/2022 | 125.61% | B of A Securities | $55 → $20 | Downgrades | Neutral → Underperform |
| 01/18/2022 | 486.58% | JMP Securities | → $52 | Initiates Coverage On | → Market Outperform |
| 10/22/2021 | 294.81% | Deutsche Bank | → $35 | Initiates Coverage On | → Hold |
| 06/17/2021 | 464.02% | B of A Securities | → $50 | Downgrades | Buy → Neutral |
| 04/26/2021 | — | Guggenheim | Initiates Coverage On | → Buy | |
| 12/10/2020 | — | Credit Suisse | Downgrades | Neutral → Underperform | |
| 09/08/2020 | 689.62% | B of A Securities | → $70 | Initiates Coverage On | → Buy |
| 09/08/2020 | 554.26% | Jefferies | → $58 | Initiates Coverage On | → Hold |
| 09/08/2020 | 667.06% | Credit Suisse | → $68 | Initiates Coverage On | → Neutral |
What is the target price for CureVac (CVAC)?
The latest price target for CureVac (NASDAQ: CVAC) was reported by B of A Securities on August 21, 2023. The analyst firm set a price target for $8.00 expecting CVAC to fall to within 12 months (a possible -9.76% downside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CureVac (CVAC)?
The latest analyst rating for CureVac (NASDAQ: CVAC) was provided by B of A Securities, and CureVac maintained their underperform rating.
When is the next analyst rating going to be posted or updated for CureVac (CVAC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CureVac, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CureVac was filed on August 21, 2023 so you should expect the next rating to be made available sometime around August 21, 2024.
Is the Analyst Rating CureVac (CVAC) correct?
While ratings are subjective and will change, the latest CureVac (CVAC) rating was a maintained with a price target of $10.00 to $8.00. The current price CureVac (CVAC) is trading at is $8.87, which is out of the analyst's predicted range.